Astrosalva Therapeutics Launches to Treat Rare Brain Diseases
The San Mateo biotech firm will use AI-driven research to develop new therapies for two rare genetic white matter disorders.
Live Poll
Do you trust private biotechnology companies to prioritize patient needs when developing new rare disease treatments?
